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Abstract: The extent of inflammatory infiltrates in arteries from
patients with giant-cell arteritis (GCA) have been described using
different terms and definitions. Studies investigating the relationship
between GCA histological features and clinical manifestations have
produced controversial results. The aims of this study were to charac-
terize and validate histological patterns in temporal artery biopsies
(TABs) from GCA patients, to explore additional histological features,
including the coexistence of different patterns, and also to investigate
the relationship of the inflammatory patterns with clinical and labora-
tory features.
We performed histological examination of TAB from patients with
GCA consecutively diagnosed between 1992 and 2012. Patterns ofont, MD, PhD, Ser nza´lez, MD,
rau, Md, PhD, and Maria C. Cid, MD, PhD
focused, one-day training session and then independently scored
77 cases. Quadratic-weighted kappa was calculated.
TAB from 285 patients (200 female/85 male) were evaluated. Four
histological inflammatory patterns were distinguished: 1 – adventitial
(n¼ 16); 2 – adventitial invasive: adventitial involvement with some
extension to the muscular layer (n¼ 21); 3 – concentric bilayer:
adventitial and intimal involvement with media layer preservation
(n¼ 52); and 4 – panarteritic (n¼ 196). Skip lesions were observed
in 10% and coexistence of various patterns in 43%. Raw agreement of
each external scorer with the gold-standard was 82% and 77% (55% and
46% agreement expected from chance); kappa¼ 0.82 (95% confidence
interval [CI] 0.70–0.95) and 0.79 (95% CI 0.68–0.91). Although
abnormalities on temporal artery palpation and the presence of jaw
claudication and scalp tenderness tended to occur more frequently in
patients with arteries depicting more extensive inflammation, no stat-
istically significant correlations were found between histological pat-
terns and clinical features or laboratory findings.
In conclusion, we have described and validated 4 histological
patterns. The presence of different coexisting patterns likely reflects
sequential steps in the progression of inflammation and injury. No clear
relationship was found between these patterns and clinical or laboratory
findings. However, several cranial manifestations tended to occur more
often in patients with temporal arteries exhibiting panarteritic inflam-
mation. This validated score system may be useful to standardize
stratification of histological severity for immunopathology biomarker
studies or correlation with imaging.
(Medicine 95(8):e2368)
Abbreviations: ESR = erythrocyte sedimentation rate, GCA =
giant-cell arteritis, PMR = polymyalgia rheumatica, TAB =
temporal artery biopsy.
INTRODUCTION
G iant-cell arteritis (GCA) is a granulomatous vasculitispreferentially affecting arteries ranging from medium to
large in size.1,2 Macrophages and CD4-positive lymphocytes
are the main component of the inflammatory infiltrates in all
artery layers and multinucleated giant cells are present in about
one half of positive biopsies.1–7 Other cell types, such
as polymorphonuclear neutrophils, eosinophils, plasma cells,
B-lymphocytes, and dendritic cells, may be occasionally
observed.1–5 Additional histological characteristics include
fragmentation of the internal elastic lamina, intimal hyperpla-
sia, and formation of new capillaries (neoangiogenesis),a and intima-media junction.1–5
linical report in 1890 by Hutchinson,8
tified the histopathological substrate of
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GCA in temporal artery biopsies (TABs) in 1932. In 1948,
Harrison10 reviewed the histological characteristics of GCA-
involved arteries and reported that inflammatory lesions in
GCA ‘‘vary a good deal in their distribution.’’ Variability
was observed between consecutive sections of the same artery
and consisted of uneven density of inflammatory cells through
the vessel wall, which included the presence of noninflamed
segments and inconstant observation of giant cells.10 These
observations still prevail in present times, since other compre-
hensive studies have recently corroborated that temporal
arteries from GCA patients may exhibit a variable extent of
inflammatory involvement, ranging from slight adventitial
infiltrates to fully developed granulomatous lesions distributed
along the entire vessel wall.4,11–13
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oral artery, other histological patterns may be part of
icture of GCA. Such patterns include (Fig. 1):
Normal temporal artery sections intermingled with(1)
involved segments: this discontinuous involvement has
been referred as skip lesions and occurs in 8% to 28% of
biopsy-proven GCA.4,14,15
Vasculitis of collateral vessels surrounding a noninflamed
temporal artery: although this picture may be part of the
histological spectrum of GCA, it can also be observed in
other diseases, including other types of systemic vasculi-
tides.4,16–20
Healing or obsolescent pattern: it is characterized by
fibrotic changes in the media and intima layers with
connective tissue replacement of damaged portions of the
media, internal elastic lamina disruption and scant
inflammatory aggregates.4 However, the healing pattern
is sometimes difficult to differentiate from aging or
atherosclerotic changes.4,11,13,21–24
Histological patterns encompassing the whole spectrum of
inflammation in GCA have been described using different termsdefinitions. On the other hand, studies investigating the
ionship between histological features in inflamed arteries
GCA patients and clinical manifestations have produced
RE 1. Active histological inflammatory patterns involving
oral arteries in giant cell arteritis (GCA). (A) Adventitial
rn, (B) Adventitial extended pattern, and (C) Concentric
er pattern. (D) Panarteritic pattern.
www.md-journal.comcontroversial results.11,19,25–34 The current study was aimed to
describe and validate the main histological patterns found in
GCA-involved temporal arteries, to examine additional histo-
logical features, including the coexistence of different patterns
in the same artery that assist in delineating a model of infiltra-
tion across the artery wall, and also to investigate the relation-
ship between the extent of the inflammatory infiltrates and
clinical and laboratory features at disease onset in a large series
of consecutively diagnosed GCA patients.
PATIENTS AND METHODS
Patient Selection and Data Collection
All patients consecutively diagnosed with biopsy-proven
GCA according to the database of the Pathology Department
(Hospital Clı´nic, Barcelona) between 1992 and 2012 were
considered for inclusion in the study. A TAB was defined as
positive when unequivocal presence of mononuclear cells was
observed in the temporal artery.4
Biopsies with inflammation limited to small vessels
surrounding a spared temporal artery were not analyzed since
there is a considerable level of uncertainty regarding diag-
nosis in this setting.4,16–19Although it is currently considered
that inflammatory infiltrates reach and invade the temporal
artery through the vasa vasorum and surrounding small
vessels,35,36 this histological finding has been repeatedly
reported in the context of other systemic vasculitides, usually
medium or small vessel vasculitis,4,16–20 malignancy or
infection.4,20
Glucocorticoid treatment previous to the TAB excision
was not considered an exclusion criterion. This allowed inves-
tigation of whether variations in the extent of inflammatory
infiltrates could be related to previous glucocorticoid therapy. In
treated patients, the prednisone dose taken at the time of TAB
and its duration were recorded.
Demographic, clinical, and laboratory findings were pro-
spectively recorded at the time of diagnosis as part of the data-
collection protocol used in our Vasculitis Research Unit. All
collected data were later transferred to a standardized database.
Recorded clinical manifestations included cranial symptoms,
neuro-ophthalmologic ischemic complications, polymyalgia
rheumatica (PMR), fever >37 8C, weight loss >4 kg, and
duration of clinically apparent disease until GCA diagnosis.
Laboratory results, such as erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), hemoglobin, platelet count,
and haptoglobin, were analyzed only from patients who did not
receive glucocorticoid therapy or were treated less than 3 days
prior to the blood extraction. The study was approved by the
Ethics Committee of our institution, and all patients signed
informed consent.
Histological Characterization
All temporal arteries from biopsy-proven GCA patients
were snap-frozen in isopentane prechilled in liquid nitrogen,
OCT embedded and stored at 80 8C. Specimens were system-
atically frozen instead of formalin-fixed, paraffin-embedded,
because of the planned use of remaining tissue for molecular
pathology studies.35–39 Four to 6mm cryostat sections were
stained with hematoxylin-eosin. Histological stratification was
carried out by 4 investigators blinded to clinical data and was
Medicine  Volume 95, Number 8, February 2016repeated in 2 different rounds by 3 of them (JHR, IV, and MCC,
the 1st round, and JHR, GM, and MCC, the 2nd round). In
cases with divergent opinion, consensus was achieved after a
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throu3rd reevaluation and this was considered the referral standard
for subsequent validation.
Histological scoring was based on the distribution of
inflammatory infiltrates through the different layers of the
artery wall. Absence or presence of multinucleated giant cells
(at 20 magnification), granuloma formation, as well as the
sectoral or diffuse inflammatory involvement of the arterial
circumference were also assessed. Granuloma was defined as
the existence of compact collections of mononuclear cells
(lymphocytes and macrophages), with or without the formation
of giant cells. Arterial inflammation was considered sectoral
when the inflammatory infiltrates involved less than two thirds
of the vessel circumference, and diffuse when inflammatory
infiltrates occupied at least two thirds of the artery circumfer-
ence. When different histological patterns occurred in serial
sections of the same biopsy, the most extensive pattern was
considered for comparison purposes.
The extent of intimal hyperplasia was quantified according
to the scoring system previously described as mild (thickness of
the intima<50% of the distance spanning from the center of the
lumen to the internal elastic lamina) and severe (between 50%
and 100% or the lumen virtually occluded).38 When different
degrees of intimal hyperplasia were observed along the arterial
sections, the highest score was considered. Disruption of the
internal elastic lamina, which may also be found in aging or
atherosclerosis, is consistently present in GCA inflamed
arteries.4,21 Although this fragmentation can be observed in
many hematoxylin-eosin stained preparations, this was not
evaluated because no specific staining for elastic fibers
was performed.
Validation of the Histological Scoring System
To analyze the level of agreement between different inves-
tigators for the histological scoring system described, charac-
teristics in 77 TABs from GCA patients were randomly selected
and blindly reevaluated by 2 investigators from the University of
Leeds (UK), 1 rheumatologist (SLM) and 1 pathologist (AC)
after a focused, 1-day training session. Data analyzed included
the main histological pattern (or the most extensive, in cases
where concomitant patterns were observed), as well as
additional findings, such as the presence of giant cells
or granuloma.
Statistical Analysis
Results are expressed as mean SD or median plus range,
where applicable. Chi-square or Fisher exact tests were used for
contingency tables. Quantitative differences between groups
were analyzed by using Student’s unpaired t-test. Data were
analyzed with the SPSS PC statistical package (version 18.0).
Differences with a value of P< 0.05 were considered
statistically significant.
For the validation study, quadratic-weighted kappa was
calculated to assess inter-rater reliability. Significance tests for
weighted kappa indicatedwhether the calculated values exceeded
0.6 (ie,whether agreementwas at least ‘‘substantial’’ according to
thresholds proposed byLandis andKoch40). Prevalence-adjusted,
bias-adjusted kappa was also calculated to assess the impact of
these issues on the measured agreement level. Stuart–Maxwell
tests of marginal homogeneity were also performed as an
additional indicator of rater bias. Kappas for each of the 4 histo-
Medicine  Volume 95, Number 8, February 2016logical patterns were then calculated separately to identify the
specific source(s) of any overall disagreement. Unweighted
kappas were calculated for the presence/absence of giant cells
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.and granuloma. Three 2-way comparisons were performed
(between the original score and each of the 2 external raters,
and between the 2 raters). The data were analyzed in Stata 11 IC
and in the free programWinPepi available from http://www.brix-
tonhealth.com/pepi4windows.html.
RESULTS
A total of 285 TABs from GCA patients (200 females and
85 males) were included in the study. All patients fulfilled 1990
American College of Rheumatology classification criteria for
GCA.41 Clinical and laboratory features of these patients are
listed in Table 1. A mean of 47 34 (standard deviation [SD])
temporal artery sections distributed in 5 2.5 slides per biopsy
were examined (Table 2).
Histopathology of GCA
Main Histological Patterns Involving the Temporal
Artery in GCA
Description and Validation of Histological Patterns in GCAApatie
the r
respeccording to the distribution of inflammatory infiltrates
gh the artery wall, 4 main histological patterns were
rentiated as follows (Fig. 1):diffe
(1) Adventitial pattern: when inflammatory cells were
restricted to the adventitia, with preservation of media
and intima layers (n¼ 16 biopsies; 5.6%).(2) Adventitial invasive pattern: when adventitial infiltration
was followed by local invasion of the muscular layer, with
integrity of the intima (n¼ 21 biopsies; 7.3%).
Concentric bilayer pattern: when inflammatory cells were(3)
infiltrating the adventitia and the intima (or the intima/
media junction), with a preserved media (n¼ 52 biopsies;
18.2%).(4) Panarteritic pattern: when the inflammatory infiltrates
were distributed through the 3 arterial layers (n¼ 196
biopsies; 68.8%).
In order to increase statistical power to perform clinical
and pathologic correlations, these 4 histological patterns were
clustered in 2 main histological groups according to their impact
on the vessel wall integrity: Mild infiltrative pattern, which
encompasses scores 1 and 2; and Extensive infiltrative pattern,
encompassing scores 3 and 4. These patterns were observed in
37 (13%) and 248 (87%) of the cases, respectively.
Extent of Intimal Hyperplasia and Other Histological
Features
Mild intimal hyperplasia score was observed in 79 arteries
and severe intimal hyperplasia in 206 biopsies. Granulomas
were detected in 201 (70.5%) samples and multinucleated giant
cells in 172 (61.4%) biopsies. Sectoral involvement of the
arterial circumference was observed in 126 (45%) of the
examined samples. Details of the histological results are listed
in Table 2.
Validation Study
Statistical results of the validation study are listed in
Table 3. The 4 histological patterns (from 1 to 4) were identified
by the pathologist (Rater 1) in 10%, 2.5%, 8%, and 77% ofnts (2 cases [2.5%] were evaluated as normal), and by
heumatologist (Rater 2) in 13%, 4%, 23%, and 60%,
ctively. Raw agreement of each UK scorer with the
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TABLE 1. Clinical and Laboratory Findings in the Whole Series of GCA Patients
Inflammatory Pattern
Characteristics
All GCA Patients
(n¼ 285)
Mild (Adventitial)
(n¼ 37)
Severe (Panarteritic)
(n¼ 248) P
General characteristics
Age in years, median (range) 77 (57–96) 78 (57–96) 77 (57–91) 0.31
Sex, no. female/no. male 200/85 24/13 176/72 0.45
Global duration of symptoms prior to
diagnosis (weeks), median (range)
8 (0–150) 12 (0–150) 8 (1–150) 0.69
Duration of cranial symptoms prior
to diagnosis (weeks), median (range)
4 (0–52) 8 (0–52) 4 (0–52) 0.042
Clinical manifestations [N (%)]
Cranial symptoms (any) 239 (83.9) 29 (78.4) 210 (84.7) 0.34
Headache 215 (75.4) 25 (67.6) 190 (76.6) 0.23
Jaw claudication 129 (45.3) 11 (29.7) 118 (47.6) 0.051
Scalp tenderness 116 (41) 10 (27) 106 (42.7) 0.08
Facial pain/edema 48 (16.8) 6 (16.2) 42 (16.9) 1
Ocular pain 28 (9.8) 4 (10.8) 24 (9.7) 0.77
Tongue pain 8 (2.8) 0 8 (3.2) 0.60
Earache 53 (18.6) 6 (16.2) 47 (18.9) 0.82
Toothache 19 (6.7) 2 (5.4) 17 (6.8) 0.99
Odynophagia 33 (11.6) 1 (2.7) 32 (12.9) 0.09
Trismus 9 (3.2) 0 9 (3.6) 0.61
Carotidynia 19 (6.7) 2 (5.4) 17 (6.8) 0.99
Abnormal temporal artery on palpation (any)

214 (75.1) 24 (64.9) 190 (76.6) 0.15
Decreased pulse 161 (56.5) 16 (43.2) 145 (58.5) 0.11
Thickened artery 155 (54.4) 12 (32.4%) 143 (57.7%) 0.005
Ischemic eventsy (any) 95 (33.3) 9 (24.3) 86 (34.7) 0.26
Irreversible ischemic complications 60 (21) 5 (13.5) 55 (22.2) 0.28
Permanent visual loss 48 (16.8) 5 (13.5) 43 (17.3) 0.64
Established diplopia 2 (0.7) 0 2 (0.8) 0.99
Stroke 7 (2.5) 0 7 (2.8) 0.60
Ischemia of other territoriesz 3 (1.1) 0 3 (1.2) 0.99
Reversible ischemic complications 35 (12.3) 4 (10.8) 31 (12.5) 0.99
Amaurosis fugax 21 (7.3) 4 (10.8) 17 (6.9) 0.49
Transient diplopia 10 (3.5) 0 10 (4) 0.37
Transient ischemic attack 3 (1.1) 0 3 (1.2) 0.99
Transient ischemia of other areas 1 (0.4) 0 1 (0.4) 0.99
Systemic manifestations
Fever 91 (31.9) 11 (29.7) 80 (32.2) 0.85
Weight loss 111 (38.9) 14 (37.8) 97 (39.1) 1
PMR 124 (43.5) 19 (51.4) 105 (42.3) 0.37
Concomitant PMR§ 111 (38.9) 18 (48.6) 93 (37.5) 0.37
Isolated PMR§ 13 (4.6) 1 (2.7) 12 (4.8) 0.99
Laboratory parameter (meanSD)
ESR, mm/hour 95 29 95 34 95 27 0.94
CRP, mg/dL 10.3 8.2 9.5 8 10.4 8.2 0.60
Hemoglobin, g/dL 11.2 1.7 10.7 1.5 11.2 1.7 0.07
Platelets, 109/L 383 139 372 144 385 139 0.65
Haptoglobin, mg/dL 3.920 1.400 3.637 1.741 3.986 1.311 0.29
Laboratory results from 248 patients treated for less than 3 days. CRP¼C-reactive protein, GCA¼ giant cell arteritis, PMR¼ polymyalgia
rheumatic, SD¼ standard deviation.
Decreased or absence of pulse and/or enlarged, nodular, indurate, swollen, or tender temporal artery on palpation.
yAmong patients with permanent visual loss, 15 also presented with amaurosis fugax, 4 transient diplopia, and 2 established diplopia. Among
patients who suffered from a stroke, 3 also developed permanent visual loss, 2 established diplopia, and 1 transient diplopia. Amaurosis fugax was
concomitantly present with transient diplopia by 2 patients.
z Permanent ischemic manifestations in other territories occurred in 3 patients, who presented with unstable angina and myocardial infarction,
intestinal ischemia requiring surgery and symptomatic large vessels stenoses, and occlusions at multiple levels, one patient each.
§ Concomitant PMR was considered when appeared simultaneously with cranial symptoms. Isolated PMR was defined by the absence of
craniofacial manifestations.
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TABLE 2. Histological Findings in the Whole Series of GCA Patients
Inflammatory Pattern
Histological Features
All GCA
Patients
(n¼ 285)
Mild
(Adventitial)
(n¼ 37)
Severe
(Panarteritic)
(n¼ 248) P
Number of biopsy sections evaluated per patient (meanSD) 47 34 48 29 47 35 0.98
Histological patterns (score)
Adventitial (1) 16 (5.6)
Adventitial extended to the media (2) 21 (7.4)
Concentric bilayer (3) 52 (18.2)
Panarteritic (4) 196 (68.8)
Other findings
Presence of granulomas 201/280 (71.8) 2 (5.4) 199/243 (81.9) <0.001
Presence of multinucleated giant cells 172/280 (61.4) 1 (2.7) 171/243 (70.4) <0.001
Sectoral involvement of the arterial wall circumference 126/281 (44.2) 33 (89.2) 93/244 (38.1) <0.001
Presence of a different histological pattern 120/280 (42.9) 29 (78.4) 91/243 (37.4) <0.001
Presence of a normal artery section 28/279 (10) 17 (45.9) 11/242 (4.5) <0.001
Severe intimal hyperplasia 206 (72.3) 3 (8.1) 203 (81.9) <0.001
GCA¼ giant cell arteritis, SD¼ standard deviation.
TABLE 3. Statistical Data From the Validation Study
Ordinal Scores for the
Main Histological Pattern
Original Score vs
Rater 1 Score
Original Score vs
Rater 2 Score
Rater 1 Score vs
Rater 2 Score
Raw agreement 81.8% 76.6% 68.8%
Expected agreement 54.9% 46.2% 47.3%
Stuart–Maxwell test P¼ 0.037 P¼ 0.020 P¼ 0.022
Overall kappa (95% CI) 0.60 (0.43–0.76) 0.57 (0.40–0.73) 0.41 (0.24–0.57)
Weighted kappa (95% CI) 0.82 (0.70–0.95) 0.79 (0.68–0.91) 0.79 (0.66–0.91)
P (weighted kappa)>0.6 P< 0.001 P< 0.001 P< 0.001
Maximum kappa 0.68 0.73 0.73
PABAK (weighted) 0.95 0.95 0.93
Kappa for pattern 1

0.58 0.64 0.58
Kappa for pattern 2

0.48 0.65 0.31
Kappa for pattern 3

0.47 0.40 0.15
Kappa for pattern 4

0.74 0.64 0.48
Binary scores for the main histological patterny
Raw agreement 96.2% 94.8% 93.5%
Kappa (95% CI) 0.86 (0.70–1.00) 0.80 (0.62–0.99) 0.76 (0.56–0.96)
P (kappa)>0.6 P< 0.001 P¼ 0.016 P¼ 0.056
PABAK 0.92 0.90 0.87
Presence of giant cells
Raw agreement 73% 70% 56%
Kappa (95% CI) 0.47 (0.29–0.65) 0.35 (0.14–0.56) 0.18 (0.01–0.36)
PABAK 0.45 0.40 0.13
Presence of granuloma
Raw agreement 79% 83% 73%
Kappa (95% CI) 0.51 (0.32–0.71) 0.61 (0.40–0.82) 0.37 (0.19–0.56)
PABAK 0.56 0.74 0.44
In initial descriptive analysis, agreement and expected agreement were calculated in Stata. Then, weighted kappas were calculated in Stata, and
checked in WinPepi, using Fleiss–Cohen (quadratic) weights. The probability that the quadratic-weighted kappa exceeded a value of 0.6 was
recorded. PABAKwas also calculated, because there were found to be a larger number of cases with panarteritis (category 4) than the number of cases
in the other categories. Overall marginal homogeneity was tested using the Stuart–Maxwell test. CI¼ confidence interval, PABAK¼ prevalence and
bias adjusted kappa.
Histological patterns: 1¼ adventitial; 2¼ adventitial invasive; 3¼ concentric bilayer; 4¼ panarteritic.
yMild (score 1 or 2) or severe (3 or 4). Rater 1¼AC (pathologist); Rater 2¼SLM (rheumatologist).
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referral-standard for the main histological pattern was 82% for
the pathologist and 77% for the rheumatologist (55% and 46%
agreement expected from chance, respectively). Quadratic-
weighted kappa values of 0.82 and 0.79, respectively, indicated
substantial agreement when partial credit was given for
agreement 1 or 2 categories (both P< 0.001). Significant
Stuart–Maxwell tests indicated consistent bias for the pathol-
ogist who tended to overestimate the proportion of pattern 1 and
underestimate the proportion of pattern 2 relative to the referral
score, and relative to the rheumatologist. Prevalence-adjusted,
bias-adjusted values (PABAK) indicated that each of the raters
almost completely agreed with the referral score when partial
credit was given (0.95 for both raters). Agreement tended to be
better for patterns 1 and 4 than for patterns 2 and 3. The 2 raters
substantially agreed with each other over the main histological
pattern.When the scores were collapsed into mild (scores 1 or 2)
and extensive (scores 3 or 4), agreement substantially improved;
raw agreement for each comparison between raters and the
Herna´ndez-Rodrı´guez et alreferral score exceeded 90%. Kappa was significantly better
than ‘‘moderate’’ (>0.6) when each rater was compared to the
referral score; comparing rater 1 to rater 2, kappa values were
FIGURE 2. (A–C) Additional histological patterns observed in temp
Normal temporal artery section (A). Vasculitis of small vessels surroundin
(D–L) Coexistence of different histological patterns in consecutive sec
GCA: Patient 1 (D–F): (D) normal section; (E) focal adventitial infla
adventitial inflammatory infiltrates; (H) concentric bilayer pattern; a
inflammation; (K) inflammatory cells crossing from the adventitia to t
pattern); and (L) cells crossing from de adventitia to the intima along
6 | www.md-journal.comslightly lower (95% confidence interval 0.56–0.96), but
increased when prevalence and bias were accounted for (0.87).
Regarding specific histological features, for which no
specific training was given, kappa coefficients for the obser-
vation of presence/absence of giant cells relative to the referral
score were 0.47 and 0.35, and for granuloma were 0.51 and 0.61,
respectively. Adjusting for prevalence and bias did not sub-
stantially alter these values, which represent only moderate
agreement with the referral standard, and agreement between
the 2 raters was relatively poor.
Other Histological Patterns and Coexisting Lesions
Although only samples showing inflammation involving
the temporal artery were considered for validation and com-
parison purposes in the current study, other histological patterns
different from the main patterns described above and always
coexisting with them were also observed. These additional
patterns included: normal temporal artery section/s; inflam-
Medicine  Volume 95, Number 8, February 2016mation of the small vessels surrounding a normal temporal
artery (in consecutive sections of arteries with adventitial
involvement only); and healing pattern (Fig. 2A–C).
oral artery biopsies from patients with giant cell arteritis (GCA).
g a spared temporal artery (B). Healing or obsolescent pattern (C).
tions of the same temporal artery biopsy in different patients with
mmation; and (F) panarteritic involvement; Patient 2 (G–I): (G)
nd (I) panarteritic inflammation; Patient 3 (J–L): (J) adventitial
he intima, leaving a preserved muscular layer (concentric bilayer
the media in a subsequent section (focal panarteritic infiltration).
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In 120 of 280 (43%) cases, a lesion different from the main
pattern was concurrently observed in other sections of the same
biopsy sample. In 72 of 196 (36.7%) arteries with panarteritic
pattern, coexisting patterns included concentric bilayer pattern
in 54 (75%) cases, adventitial and adventitial invasive pattern,
in 9 and 2 cases, respectively, healing pattern in 6 and a normal
pattern in 1. In 19 of 52 (36.5%) arteries with a concentric
bilayer pattern as the most severe pattern, 14 and 4 included
sections with an adventitial or adventitial invasive pattern,
respectively, and 1 a normal pattern. Among 16 of 21 (76%)
arteries showing an adventitial invasive pattern, 15 also showed
coexisting adventitial lesions and in 1, a healing pattern. In 13 of
16 (81%) arteries with adventitial inflammation only, 3 and
10 cases had a coexisting healing or normal pattern, respectively
Two or more coexisting patterns were observed in
24 temporal arteries. Overall, healing pattern and normal sec-
tions were detected in 10 and 28 cases, respectively. Examples
of coexisting different histological patterns in sequential
temporal artery sections are illustrated in Figure 2D–L.
Correlations Between Histopathological Features
The number of temporal artery sections evaluated in groups
with mild or extensive infiltrative patterns was similar (Table 2).
The presence of extensive artery inflammation strongly
correlated with severe intimal hyperplasia (P< 0.001). Other
parameters indicating more developed lesions, such as the pre-
sence of granulomas or giant cells, were more frequently
observed in arteries with the most extended patterns. On the
contrary, sectoral involvement of the arterial wall circumference
and the coexistence of different histological patterns in serial
sections of the same artery, including a normal pattern, occurred
more commonly in arteries with themildest inflammatory scores.
All the histological associations are depicted in Table 2.
Influence of Glucocorticoid Treatment on
Histological Changes
A total of 174 (61%) patients were glucocorticoid naive at
the time of the TAB and 91 (32%) patients had received
prednisone at 1mg/kg/day, for 1 to 2 days (n¼ 39; 13.7%),
Medicine  Volume 95, Number 8, February 2016for 3 to 6 days (n¼ 27; 9.5%), or for 7 to 28 days (n¼ 25; 8.8%).
In addition, 20 (7%) patients had been treated for a median of
300 days (range 90–876 days) with a median dose of prednisone
TABLE 4. Data of Histological Features With Regard to Glucocor
Inflammatory Extent
Time Receiving
Glucocorticoids Mild/adventitial Severe/panarteritic Prese
Untreated 29 (17) 145 (83) 59 (
Up to 1 month

7 (11) 84 (89) 40 (
1–2 days 1 (2.5) 38 (97.5) 16 (
3–6 days 4 (15) 23 (85) 14 (
7–28 days 2 (8) 13 (92) 10 (
>3 monthsy 1 (5) 19 (95) 9 (
Values as n (%). Fisher exact test P values: For inflammatory ext
treated> 3 months: P¼ 0.32. For presence/absence of giant cells or granulom
Treated with prednisone or equivalent at 1mg/kg/day during the 1st m
yTreated with prednisone or equivalent at a mean dose of 5mg/day (ran
previous diagnosis of polymyalgia rheumatica that later evolved to an ove
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.of 5mg/day (range 2.5–5mg/day) for a previous diagnosis of
isolated PMR that later evolved to an overt GCA. No significant
differences in the proportion of the different infiltrative patterns
were found between patients untreated (adventitial/mild 17%,
panarteritic/extensive 83%), and those receiving full doses of
prednisone during the 1st month (mild 11%, extensive 89%), or
those treated with low doses for more than 3 months (mild 5%,
extensive 95%). No clear differences were either found with
regard to the presence of giant cells or granuloma and intimal
hyperplasia degree between untreated and treated patients (see
detailed results in Table 4).
Clinical-Histological Correlations
No clear relationship was found between the extent of
inflammatory infiltrates and age, gender, cranial manifestations
or neuro-ophthalmic ischemic complications, presence of
systemic manifestations, such as fever, weight loss or PMR,
or any of the laboratory findings analyzed (Table 1). However,
patients with TAB disclosing a panarteritic pattern tended to
present more often with jaw claudication and scalp tenderness
than those with arteries showing adventitial involvement. These
patients also had more abnormalities on temporal artery palpa-
tion, mainly temporal artery thickening, and into a lesser extent,
decreased pulse than those with adventitial involvement
(Table 1). Whereas duration of systemic symptoms were similar
in both groups, cranial symptoms had longer duration in patients
with arteries showing adventitial inflammation.
A significant correlation was found between pulse
reduction on temporal artery palpation and the degree of
intimal hyperplasia. A decreased or absent pulse in temporal
arteries was observed in 44.9% and 60.9% of patients with
mild and severe intimal hyperplasia, respectively (P¼ 0.016).
The presence or absence of giant cells and the extent of
intimal hyperplasia did not correlate with the remaining
clinical symptoms, including cranial and neuro-ophthalmic
ischemic manifestations, or laboratory parameters (data not
shown).
DISCUSSION
Description and Validation of Histological Patterns in GCAIn 1932, Horton et al9 reported the 1st histological descrip-
tion of GCA in 2 patients. Since then, histopathological features
observed in temporal arteries from patients with GCA have
ticoid Therapy
Giant Cells Granuloma
Intimal
Hyperplasia
nce Absence Presence Absence Mild Severe
34) 47 (27) 125 (73) 113 (66) 52 (30) 122 (70)
45) 23 (29) 57 (71) 48 (55) 23 (25) 68 (75)
43) 8 (22) 29 (78) 21 (57) 11 (28) 28 (72)
52) 8 (30) 19 (70) 13 (48) 6 (22) 21 (78)
46) 7 (29) 17 (71) 14 (54) 6 (24) 19 (76)
45) 9 (45) 11 (55) 11 (55) 4 (20) 16 (80)
ent: untreated versus treated< 1 month: P¼ 0.06; untreated versus
a or intimal hyperplasia score P values were not statistically significant.
onth.
ge 2.5–5mg/day) for a median of 300 days (range 90–876 days) for a
rt giant-cell arteritis.
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ranged from slight cellular inflammatory aggregates in the outer
layer to a granulomatous inflammation involving the entire
artery wall, with or without multinucleated giant cells.4,11–13,42
Variations in the spectrum of inflammatory changes
observed in the temporal arteries from patients with GCA have
been reported with different names. Terms such as ‘‘typical or
classical GCA’’4,43 or ‘‘granulomatous arteritis’’27 illustrated
TABs with a panarteritic granulomatous inflammation, includ-
ing the frequent presence of multinucleated giant cells. ‘‘Aty-
pical GCA’’4,43 or ‘‘GCA variant with predominantly intimal
changes’’27 have been reported to define lighter inflammatory
infiltrates without granuloma formation, mainly confined to the
adventitia. Lie4 confirmed the coexistence of both (typical and
atypical) patterns in the same biopsy after multiple-block serial
sections in a previous study of 1109 TABs. Cavazza et al19
recently analyzed clinical and histological features of 317
inflamed temporal arteries from patients with GCA. Although
14.5% of TAB revealed small-vessel and vasa vasorum vascu-
litis with a spared temporal artery, in the remaining 85.5% of
samples, the 2 main histological patterns involving the temporal
artery were categorized as ‘‘transmural inflammation’’ and
‘‘inflammation limited to the adventitia,’’ which according
to our classification, accounted for extensive and mild infil-
Herna´ndez-Rodrı´guez et altrative involvement, respectively. These patterns were found in
93.4% and 6.6% of biopsies,19 a similar proportion to that found
in our study.
FIGURE 3. Hypothetical model of the sequential invasion of the arte
8 | www.md-journal.comThe concentric bilayer pattern has been seldom reported,
sometimes as atypical GCA.4,11,27,43 Cavazza et al19 recently
reported that this pattern (named as ‘‘concentric rings’’) fre-
quently occurred in arteries with transmural inflammation.
Nevertheless, no information was provided about the frequency
of this pattern with respect to the others or its specific corre-
lations with clinical features.19 In the present series, a con-
centric bilayer pattern was observed in 106 arteries, accounting
for 37.2% of all TAB. In 52 (18.2%) cases, concentric bilayer
pattern was the most intense pattern and in 54 (18.9%) of them,
it coexisted with adjacent panarteritic involvement.
In our series, skip lesions were observed in 10% of the
samples. A healing pattern was also observed along with the
whole spectrum of active lesions in 3.6% of arteries. Because a
healing pattern had been previously reported in patients with
delayed biopsies, with or without long-term glucocorticoid
treatment,13,22–24,39,44,45 the novel finding of healing lesions
close to sections showing any type of inflammatory pattern
suggests that these scarring changes are part of the evolving
reparative process. Healing changes were similarly observed in
sequential sections from arteries with panarteritic and adven-
titial pattern. Therefore, its presence does not seem to be clearly
associated with any specific active pattern.
Medicine  Volume 95, Number 8, February 2016Based on the different histological patterns observed in
arteries from GCA patients, and on the fact that different
inflammatory patterns may coexist with normal sections and/
ry by Inflammatory cells according to our histological findings.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
or a healing pattern in sequential sections of the same temporal
Medicine  Volume 95, Number 8, February 2016artery
been
invas
(1)
(2)
(3)
resul
temp
Copy, a dynamic model of arterial inflammation in GCA has
postulated and depicted in Figure 3. The steps of this
ive process would be as follows:
the first contact of inflammatory cells with the artery would
occur through the small vessels of the adventitia, as
supported by previous studies35,38 and by the fact that
the adventitial involvement invariably occurs in all
GCA patients
lymphocytes and macrophages would subsequently pene-
trate through the muscular layer to reach the intima38
once in the inner layer, the inflammatory cells might
continue their progression by horizontal spreading through
the intima and the adventitia, with preservation of the
media layer, which has been considered an immunopri-
vileged site46 (concentric bilayer pattern)(4) panarteritic involvement may eventually result from
progression of the previous stages with massive infiltration
of the vessel wall and finally(5) a reparative process would occur in the disrupted vessel
wall with intimal thickening and fibrotic changes in the
media (healing or obsolescent pattern)
As in our series, other studies have observed a remarkable
intimal hyperplasia in all histological categories.4,27,43 How-
ever, our results corroborate a striking correlation between the
extent of inflammatory infiltrates and the severity of intimal
thickening, as previously described in a morphometric study of
inflamed temporal arteries.47 Several investigators have
observed that additional structural changes, such as internal
elastic lamina disruption also correlate with the extent of intima
hyperplasia and the density of artery wall inflammatory infil-
trates.38 In this regard, multiple inflammatory pathways, in
which infiltrating lymphocytes, macrophages, and their pro-
ducts (cytokines, metalloproteinases, growth and angiogenic
factors) participate, may lead to tissue damage, neoangiogen-
esis, and intimal proliferation.33,35–39 Therefore, the extension
of inflammatory infiltrates in the artery wall might be con-
sidered an important determinant of the development of
intimal hyperplasia.
We have also confirmed that glucocorticoid therapy at full-
doses, at least during the first month, do not seem to influence
the morphology and extent of the inflammatory infiltrates.3,48
Indeed, low doses (ie, 2.5–10mg/day) of prednisone do not
preclude the development of full-blown vascular inflammatory
infiltrates in GCA in some patients receiving low-dose pre-
dnisone for apparently isolated PMR.48 In this study, we did not
perform biopsies from patients treated with high doses of
prednisone beyond 1 month, and therefore, we could not assess
the impact of treatment on morphology beyond this period. In
this regard, previous studies have shown that, overtime, biopsies
performed in long-term treated patients, are more likely to
disclose healing lesions.49 In addition, in a small series of
biopsies performed before and after 1 year of treatment, the
panarteritic initial pattern evolved into healing changes in all
cases.39 Although, as shown in the present study, healing lesions
may develop early and spontaneously, it is likely that gluco-
corticoid therapy helps this process since increase in the
expression of fibrogenic growth factors in temporal arteries
was observed after 1 year of treatment.39The relationship between clinical findings or blood test
ts and the density of inflammatory infiltrates within the
oral artery has been repeatedly analyzed with conflicting
right # 2016 Wolters Kluwer Health, Inc. All rights reserved.results (Table 5). Similarly to previous studies,11,25–29 we did
not find clear correlations between inflammatory changes in
temporal arteries and the clinical and biological parameters
analyzed, including the presence of neuro-ophthalmic ischemic
complications.11,27,28 No apparent explanation can be provided
for the finding of longer duration of cranial symptoms in
patients with arteries showing adventitial pattern. Furthermore,
no correlations were found between the magnitude of intimal
hyperplasia or the presence of giant cells and GCA clinical
symptoms, including the development of ischemic compli-
cations. However, intimal hyperplasia degree was positively
associated with decreased pulse in temporal arteries on palpa-
tion. Such finding might reflect a local effect without necess-
arily conveying distal consequences in smaller vessels
supplying ophthalmic territories.
On the other hand, several studies have reported a relation-
ship between histological changes at temporal artery level and
GCA disease-related manifestations. Cavazza et al19 found that
GCA patients with transmural inflammation present more fre-
quently with cranial manifestations, in particular headache and
abnormalities of the temporal arteries, than those showing an
arterial inflammation limited to adventitia. In the same sense, in
our study, patients with temporal arteries showing panarteritic
involvement had more frequently an abnormal artery palpation
and tended to present more often with jaw claudication and
scalp tenderness. Another study showed that PMR was more
frequently presented by GCA patients with atypical (adventi-
tial) inflammatory infiltrates in the temporal artery than by
those with a transmural granulomatous reaction.28 Several
studies, not always including consecutively selected patients,
have reported an association between the development of neuro-
ophthalmic ischemic complications and the presence of trans-
mural inflammation,30 giant cells,31,32 or intimal thickening
(Table 5).32–34 Two studies reported that GCA patients with
biopsies showing nongranulomatous infiltrates tended to have
higher ESR and C-reactive protein, and lower hemoglobin
levels than those with granulomatous inflammatory lesions.11,28
In contrast, other authors found that patients with transmural
inflammation had a more intense systemic inflammatory
response (including anemia and higher ESR values) than those
without transmural inflammation.30
Overall, the discrepancies between our results and those
with positive correlations between clinical manifestations
and histological lesions might in part be explained by the
fact that we identified coexisting patterns in 43% of TAB
after an extensive examination (a mean of 47 temporal artery
sections per biopsy). Variability in results or trends is prob-
ably related to the number of the examined sections and the
search for concomitant patterns, which may have been
missed in smaller studies. Moreover, studies in which
patients were not consecutively included may have been
subjected to selection bias.
Previous attempts to study the level of agreement by
different investigators in scoring some histological features
in biopsy-proven GCA, such as the extent of inflammation
and quantification of giant cells, have been difficult.23,50 In this
regard, a poor inter-rater agreement regarding presence/absence
of giant cells and granuloma was also found in the validation
study. However, our scoring system has demonstrated to be
reliable and reproducible when investigators underwent a brief
training session of TAB examination.
Description and Validation of Histological Patterns in GCACurrently, investigation of surrogate diagnostic modalities
based on temporal artery imaging (ultrasound or MRI) is in
successful progress.51 It is unclear whether imaging studies may
www.md-journal.com | 9
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detect incomplete or mild histopathological changes, such as
inflammation limited to the adventitia or small-vessel vasculitis
surrounding a spared temporal artery.19,52 Our scoring system
may be useful for imaging/histology correlations.
In conclusion, in this large series of patients with GCA,
4 histological patterns have been described and validated. A
dynamic model of arterial invasion, likely reflecting sequential
steps in the progression of inflammation and injury, has been
postulated. Although no clear relationship was found between
the described patterns and clinical or laboratory findings at
disease diagnosis, abnormalities on temporal artery palpation
and several cranial symptoms, such as jaw claudication and
scalp tenderness, tended to occur more frequently in patients
with TAB disclosing a panarteritic pattern. The description of
these patterns and its validation may be useful for homogen-
ization and comparison of histological data from different
sources and for stratification of histological severity for immu-
nopathologic biomarker studies or correlation with imaging.
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